Skip to main content
Menu

AlphaLISA SureFire Biotin-Free Human and Mouse Total SMARCA2 Detection Kit, 500 Assay Points

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total SMARCA2 assay is a sandwich immunoassay for quantitative detection of total SMARCA2 in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 10 µL

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total SMARCA2 assay is a sandwich immunoassay for quantitative detection of total SMARCA2 in cellular lysates using Alpha Technology.

Product variants
Compare all
Remove all
Add to compare Add to compare
Remove
Unit Size: 100 Assay Points
Part #:
ASBF-TSMCA2-A-HV
List price
USD 737.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 500 Assay Points
Part #:
ASBF-TSMCA2-A500
List price
USD 2,490.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 10,000 Assay Points
Part #:
ASBF-TSMCA2-A10K
List price
USD 14,982.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 50,000 Assay Points
Part #:
ASBF-TSMCA2-A50K
List price
USD 47,624.00
Your price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

SMARCA2 (SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 2), also known as BRM, is a catalytic ATPase subunit of the SWI/SNF (BAF) chromatin remodeling complex that uses ATP hydrolysis to reposition nucleosomes and regulate chromatin accessibility at gene regulatory elements. SMARCA2 and its paralog SMARCA4 (BRG1) are mutually exclusive catalytic subunits of distinct SWI/SNF complex assemblies, and their relative expression and activity determine the composition and targeting of SWI/SNF complexes across cell types. SMARCA2 is frequently silenced by promoter methylation or other epigenetic mechanisms in non-small cell lung cancer and other tumor types, and its loss is associated with oncogenic transformation and altered differentiation. Critically, SMARCA4-mutant cancers — including SMARCA4-deficient thoracic sarcomas and a subset of NSCLC — exhibit synthetic lethality with SMARCA2 loss or inhibition, as these tumors become entirely dependent on SMARCA2 for residual SWI/SNF function. This synthetic lethal relationship has driven the development of SMARCA2-targeted PROTACs and inhibitors as precision oncology strategies for SMARCA4-mutant cancers, with several compounds entering clinical trials.

The AlphaLISA SureFire Biotin-Free Human and Mouse Total SMARCA2 Detection Kit is a sandwich immunoassay for the quantitative detection of total SMARCA2 in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Biotin Free kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies
  • Biotin rich samples

AlphaLISA SureFire Biotin Free kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Biotin Free assay principle

The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).

The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Total-AlphaLISA SureFire Ultra Biotin Free assay principle

 

Total-AlphaLISA SureFire Biotin Free two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol alphalisa surefire ultra biotin free total assay

Total-AlphaLISA SureFire Biotin Free one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.

1 plate assay protocol alphalisa surefire ultra biotin free total assay

Assay validation

PROTAC mediated degradation of SMARCA2

HeLa and LNCaP cells were seeded in a 96-well plate (40,000 cells/well for HeLa and 60,000 cells/well for LNCaP) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ACBI1 for 4 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). SMARCA2 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells for HeLa and 6,000 cells for LNCaP) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, ACBI1 (SMARCA2/4 PROTAC) treatment resulted in a decrease in SMARCA2 levels, while ERK levels remained unchanged.

Pharmacological Validation (Inhibition) of SMARCA2 Total assay
Pharmacological Validation (Inhibition) of SMARCA2 Total assay

Assay specificity/selectivity

Specificity of Total SMARCA2 assay

Total SMARCA2 expression levels were assessed in parallel with Total SMARCA4 in a panel of relevant cell lines.

SMARCA2 and SMARCA4 Total levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (4,000 adherent cells and 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, SMARCA2 and SMARCA4 expression is dependent upon cell type. SMARCA2 is expressed in A549 cells, whilst SMARCA4 is undetectable. Conversely, SMARCA4 is expressed in Caco-2 cells where SMARCA2 is undetectable.

These results demonstrate the specificity of the SMARCA2 and SMARCA4 assays as these 2 proteins share more than 70% sequence identity.

Specificity of SMARCA4 Total assay in various cell lines

Assay versatility

SMARCA2 expression in various cell lines

Adherent cells were seeded in a 96-well plate (40,000 cells/well) in complete medium incubated overnight at 37°C, 5% CO2. Suspension cells were harvested, washed, and seeded in a 96-well plate (400,000 cells/well) in HBSS.

Cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). SMARCA2 Total levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (4,000 adherent cells and 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

SMARCA2 is expressed in a wide variety of cell lines. Very high levels of expression were detected in HeLa, U937 and THP-1 cells.

Versatility of SMARCA2 Total assay in various cell lines

Assay sensitivity

Assay sensitivity - cell lysate dilution

Cell lysate was prepared from HeLa cells seeded in a T175 flask and cultured to confluence and lysed in 5 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted in Lysis Buffer and SMARCA2 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect SMARCA2 expression in less than 250 cells/datapoint.

SMARCA2 Total assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Biotin-Free
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
SMARCA2
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
Alpha
Therapeutic Area
Oncology
Unit Size
500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

1-4 of 4 Resources
Brochure Icon
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...

Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Loading...

Revvity AI Assistant Beta

Scroll Icon